- Home
- MLAB vs SITC Comparison
MLAB vs SITC Comparison
Compare MLAB & SITC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLAB
- SITC
- Stock Information
- Founded
- MLAB 1982
- SITC 1965
- Country
- MLAB United States
- SITC United States
- Employees
- MLAB N/A
- SITC N/A
- Industry
- MLAB Industrial Machinery/Components
- SITC Real Estate Investment Trusts
- Sector
- MLAB Industrials
- SITC Real Estate
- Exchange
- MLAB Nasdaq
- SITC Nasdaq
- Market Cap
- MLAB 692.9M
- SITC 830.0M
- IPO Year
- MLAB N/A
- SITC 1993
- Fundamental
- Price
- MLAB $134.22
- SITC $15.46
- Analyst Decision
- MLAB Hold
- SITC Hold
- Analyst Count
- MLAB 2
- SITC 10
- Target Price
- MLAB $140.00
- SITC $39.03
- AVG Volume (30 Days)
- MLAB 36.5K
- SITC 1.1M
- Earning Date
- MLAB 02-03-2025
- SITC 02-11-2025
- Dividend Yield
- MLAB 0.47%
- SITC 1.69%
- EPS Growth
- MLAB N/A
- SITC 757.51
- EPS
- MLAB N/A
- SITC 13.71
- Revenue
- MLAB $228,380,000.00
- SITC $451,683,000.00
- Revenue This Year
- MLAB $11.32
- SITC N/A
- Revenue Next Year
- MLAB $5.98
- SITC N/A
- P/E Ratio
- MLAB N/A
- SITC $1.13
- Revenue Growth
- MLAB 6.88
- SITC N/A
- 52 Week Low
- MLAB $83.68
- SITC $15.25
- 52 Week High
- MLAB $141.17
- SITC $64.44
- Technical
- Relative Strength Index (RSI)
- MLAB 64.30
- SITC 31.41
- Support Level
- MLAB $121.03
- SITC $15.26
- Resistance Level
- MLAB $138.00
- SITC $15.65
- Average True Range (ATR)
- MLAB 4.44
- SITC 0.32
- MACD
- MLAB 1.38
- SITC 0.20
- Stochastic Oscillator
- MLAB 79.25
- SITC 20.71
About MLAB Mesa Laboratories Inc.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.
About SITC SITE Centers Corp.
SITE Centers Corp is a United States-based self-administered and self-managed REIT that operates as a fully integrated real estate company. The company is engaged in the business of owning, leasing, acquiring, redeveloping, developing and managing shopping centers.